Fiber supplement increases insulin secretion in type 2 diabetic patients

March 21, 2018 by Ellen Goldbaum, University at Buffalo
Fiber supplement increases insulin secretion in type 2 diabetic patients
Credit: University at Buffalo

University at Buffalo researchers have found that taking a fiber supplement can help patients with type 2 diabetes boost their insulin secretion even after eating a high-fat, high-carbohydrate meal.

The research was presented on March 20 at ENDO 2018, the annual meeting of the Endocrine Society in Chicago.

The study was led by Paresh Dandona, MD, Ph.D., SUNY Distinguished Professor and chief of the Division of Endocrinology in the Jacobs School of Medicine and Biomedical Sciences at UB. Dandona, who sees at UBMD Internal Medicine, is an expert in research and treatment, and a pioneer in exploring novel ways that patients with both Type 1 and type 2 diabetes can achieve better blood sugar control.

The current work builds on his team's previous research, published last year in the Journal of Clinical Endocrinology and Metabolism, showing that adding fiber to the diet after a high-fat, high-carbohydrate meal, which is known to increase inflammation, will have beneficial anti-inflammatory and metabolic effects.

"Dietary fiber is known to reduce the incidence of diabetes and cardiovascular disease in large epidemiological studies," said Dandona. He noted that his team at UB provided the first mechanistic evidence—meaning evidence aimed at determining a mechanism—at cellular and molecular levels that fiber exerts an anti-inflammatory effect, lowering glucose levels and boosting insulin concentration in normal subjects.

The current study was aimed at finding out how fiber might function in patients with type 2 diabetes.

Dandona and his colleagues studied 12 patients at the Clinical Research Center, a part of the UB Division of Endocrinology, Diabetes and Metabolism.

Levels of , insulin and proteins involved in inflammation were measured in the patients after they consumed a high-fat, high-carbohydrate meal. The same patients consumed the same meal a week later, but this time they also consumed Fiber One (a commercially available supplement) before and after the meal.

"After eating the meal, diabetics' increased significantly after the fiber. However, this increase wasn't sufficient to reduce their ," said Dandona.

The fiber supplement also resulted in suppressing comprehensively inflammation and oxidative stress in these patients.

"An increase in dietary content of fiber, whether through food or a supplement, should be encouraged in order to reduce oxidative and inflammatory stress and hence, a tendency to induce resistance," said Dandona.

Explore further: Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

Related Stories

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

High-energy breakfast promotes weight loss

March 18, 2018
In patients with obesity and type 2 diabetes, a meal schedule that includes a high-energy breakfast promotes weight loss, improves diabetes and decreases the need for insulin, new research from Israel reports. The study results ...

Testosterone replacement makes Type 2 diabetic men more sensitive to insulin

November 30, 2015
Men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment.

Fiber-fermenting bacteria improve health of type 2 diabetes patients

March 8, 2018
The fight against type 2 diabetes may soon improve thanks to a pioneering high-fiber diet study led by a Rutgers University-New Brunswick professor.

Study findings significant for treating infections in Type 1 diabetes

May 16, 2013
A small University at Buffalo study has found for the first time that in Type 1 diabetics, insulin injections exert a strong anti-inflammatory effect at the cellular and molecular level, while even small amounts of glucose ...

Study suggests drug significantly improves glycemic control in type one diabetics on insulin

June 15, 2011
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control ...

Recommended for you

A novel insulin accelerant

October 17, 2018
Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.